Protalix BioTherapeutics (PLX)

Protalix BioTherapeutics

PLX

#8584

Rank

£0.11 B

Marketcap

🇮🇱 Israel

Country

£1.51

Share price

3.28%

Change (1 day)

5.45%

Change (1 year)

💊 Pharmaceuticals 🧬 Biotech

Protalix BioTherapeutics - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year	Net assets	Change
2023-12-31	$£26.34 M	-399.6%
2022-12-31	$-£8.8 Million	96.68%
2021-12-31	$-£4.48 Million	-77.46%
2020-12-31	$-£19.84 Million	-63.01%
2019-12-31	$-£53.63 Million	28.73%
2018-12-31	$-£41.66 Million	91.14%
2017-12-31	$-£21.8 Million	170.1%
2016-12-31	$-£8.07 Million	-209.98%
2015-12-31	$£7.33 M	-120.54%
2014-12-31	$-£35.72 Million	118.62%
2013-12-31	$-£16.34 Million	686.52%
2012-12-31	$-£2.08 Million	-87.62%
2011-12-31	$-£16.78 Million	128.73%
2010-12-31	$-£7.34 Million	-174.73%
2009-12-31	$£9.81 M	-67.56%
2008-12-31	$£30.25 M	-5.61%
2007-12-31	$£32.05 M	158.57%
2006-12-31	$£12.39 M	250.77%
2005-12-31	$£3.53 M	1270.79%
2004-12-31	$£0.25 M	-29.63%
2003-12-31	$£0.36 M	-26.21%
2002-12-31	$£0.49 M	-23.89%
2001-12-31	$£0.65 M

Net assets for similar companies or competitors

Company	Net assets	differencediff.	Country
Amicus Therapeutics FOLD	£0.14 B	451.30%	🇺🇸 USA
Neurocrine Biosciences NBIX	£2.16 B	8,282.09%	🇺🇸 USA
Pfizer PFE	£73.77 B	285,246.98%	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	£5.08 B	19,581.23%	🇮🇱 Israel

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Protalix BioTherapeutics (PLX) - Net assets

Net assets on the balance sheet as of September 2024 : £25.85 Million